Important New Opioid REMS Training Module

The New England Journal of Medicine (NEJM), in collaboration with Boston University’s Safer/Competent Opioid Prescribing Education (SCOPE of Pain) program, has launched a new opioid Risk Evaluation and Mitigation Strategy (REMS) training activity using their adaptive learning technology platform.

In response to the opioid epidemic, which claims the lives of more than 115 Americans each day, health care providers have faced pressure to reduce the number of prescriptions written for opioids. However, with an estimated 20 percent of the adult population suffering from chronic pain, the need for opioids to treat pain in certain patients remains. Recognizing this reality, the U.S. Food and Drug Administration offers training activities through the opioid REMS program, which is financed by pharmaceutical manufacturers. The training activities focus on best practices for the safe prescribing of opioids and are offered to approved providers free of charge.

Unlike traditional training modules, the NEJM Knowledge+ Pain Management and Opioids CME Course measures the participant’s accuracy in responding to questions and their level of confidence in their answers to develop a custom “adaptive learning” algorithm. The algorithm then tailors the content of the module to better suit the learner’s individualized needs, thus improving their overall mastery of the material.

PAs are among the health professionals who are encouraged to take advantage of this innovative training offering. The activity consists of more than 60 case-based multiple-choice questions and counts for up to 10 AAPA Category 1 CME credits. To access the free module, please visit the NEJM Knowledge+ website.

Disclosure of Support

This activity is supported by an independent educational grant from the Opioid Analgesic REMS Program Companies. Please see this site for a listing of REMS Program Companies. This activity is intended to be fully compliant with the Opioid Analgesic REMS education requirements issued by the U.S. Food and Drug Administration. 

Accreditation Statement

The Massachusetts Medical Society is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

AMA Credit Designation Statement

The Massachusetts Medical Society designates this enduring material for a maximum of 10 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

NCCPA Accreditation Statement

PAs may claim a maximum of 10 Category 1 credits for completing this activity. NCCPA accepts AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society.